Skip to content

Clinical trials

Completed Lysosomal Storage Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lysosomal Storage Diseases Status: Completed Country / region: France Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20115
20131
20142
20151
20161
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.4
Shire3
BioMarin Pharmaceutical2
ZevraDenmark2
Azafaros B.V.1
National Institute of Neurological Disorders and Stroke (NINDS)1
Spark Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lysosomal Storage Diseases14
Cholesterol Ester Storage Disease4
Wolman Disease4
Mucopolysaccharidosis II3
Mucopolysaccharidosis IV2
Niemann-Pick Disease, Type C2
Sudden Infant Death2
Gangliosidoses, GM21
Gangliosidosis, GM11
Genetic Diseases, Inborn1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.